Home›Stock Screener›Astal Laboratories›Financial Statements

Astal Laboratories Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Astal Laboratories (ASTALLTD) reported revenue ₹139 Cr, net profit ₹10 Cr and EPS ₹9.50, with a net profit margin of 14.1% and ROE of 25.0%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see ASTALLTD stock overview.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 14.06% 2025 data
EBITDA Margin 20.31% 2025 data
Operating Margin 20.00% 2025 data
Return on Assets 14.29% 2025 data
Return on Equity 25.00% 2025 data

Balance Sheet Ratios

Current Ratio 46.00 2025 data
Equity Ratio 57.14% 2025 data
Asset Turnover 1.02 2025 data

ASTALLTD Revenue, Net Profit & EBITDA — Year-on-Year Growth

ASTALLTD YoY (March 2025 vs Period) — revenue +117.2%, net profit +11.1%, EBITDA +15.4%, expenses +138.5%. See ASTALLTD price to book ratio to compare market price against book value per share.

Revenue Growth
+117.2%
Year-over-Year
Net Profit Growth
+11.1%
Year-over-Year
EBITDA Growth
+15.4%
Year-over-Year
Expense Growth
+138.5%
Year-over-Year
Assets Growth
+70.3%
Year-over-Year
Equity Growth
+56.5%
Year-over-Year
Operating Cash Flow Growth
-116.7%
Year-over-Year
Investing Cash Flow Growth
-33.3%
Year-over-Year
Financing Cash Flow Growth
-83.3%
Year-over-Year

ASTALLTD Income Statement — Revenue, EBITDA & Net Profit

Astal Laboratories revenue ₹139 Cr, EBITDA ₹15 Cr, net profit ₹10 Cr, EPS ₹9.50 (None) — net profit margin 14.1%. Check ASTALLTD market cap trends to track the company's total market size over time.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 139 64 24 4 0 0 0 0 0 0 0 0
Expenses 124 52 23 4 0 0 0 0 0 0 0 0
EBITDA 15 13 1 0 0 0 0 0 0 0 0 0
Operating Profit Margin % 12.00% 20.00% 5.00% -4.00% 0.00% 12.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 1 1 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 13 12 1 0 0 0 0 0 0 0 0 0
Tax 3 3 0 0 0 0 0 0 0 0 0 0
Net Profit 10 9 1 0 0 0 0 0 0 0 0 0
Earnings Per Share (₹) 9.50 9.08 1.55 0.04 -0.04 0.02 -0.07 -0.21 -0.02 0.01 0.02 0.46

ASTALLTD Balance Sheet — Assets, Liabilities & Shareholders' Equity

ASTALLTD total assets ₹63 Cr, total equity ₹36 Cr, total liabilities ₹ Cr (2025) — ROE 25.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 63 37 10 5 5 5 5 5 5 5 5
Current Assets 46 27 6 0 0 5 5 5 5 5 5
Fixed Assets 11 1 0 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 52 36 10 5 5 5 5 5 5 5 5
LIABILITIES
Total Liabilities
Current Liabilities 1 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 36 23 5 5 5 5 5 5 5 5 5
Share Capital 10 10 4 4 4 4 4 4 4 4 4
Reserves & Surplus 22 14 1 1 1 1 1 1 1 1 1

ASTALLTD Cash Flow Statement — Operating, Investing & Financing

Astal Laboratories operating cash flow ₹-13 Cr, investing ₹-8 Cr, financing ₹3 Cr, net cash flow ₹-17 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -13 -6 -1 0 0 0 0 0 0 0 0
Investing Activities -8 -6 0 0 0 0 0 0 0 0 0
Financing Activities 3 18 1 0 0 0 0 0 0 0 0
Net Cash Flow -17 6 0 0 0 0 0 0 0 0 0